BR9400021A - Uso de um composto, compostos, processo para a produção de um éter e composição farmacêutica - Google Patents
Uso de um composto, compostos, processo para a produção de um éter e composição farmacêuticaInfo
- Publication number
- BR9400021A BR9400021A BR9400021A BR9400021A BR9400021A BR 9400021 A BR9400021 A BR 9400021A BR 9400021 A BR9400021 A BR 9400021A BR 9400021 A BR9400021 A BR 9400021A BR 9400021 A BR9400021 A BR 9400021A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- formula
- hydrogen
- group
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 2
- 210000002569 neuron Anatomy 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 208000013016 Hypoglycemia Diseases 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 231100000644 Toxic injury Toxicity 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US113593A | 1993-01-06 | 1993-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9400021A true BR9400021A (pt) | 1994-07-26 |
Family
ID=21694554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9400021A BR9400021A (pt) | 1993-01-06 | 1994-01-05 | Uso de um composto, compostos, processo para a produção de um éter e composição farmacêutica |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0612730B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2501298B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR940018094A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1097006A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE154931T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU681601B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9400021A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2110337A1 (cg-RX-API-DMAC10.html) |
| CZ (1) | CZ2294A3 (cg-RX-API-DMAC10.html) |
| DE (1) | DE69311887T2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK0612730T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2105061T3 (cg-RX-API-DMAC10.html) |
| FI (1) | FI940041L (cg-RX-API-DMAC10.html) |
| GR (1) | GR3024891T3 (cg-RX-API-DMAC10.html) |
| HU (2) | HUT66061A (cg-RX-API-DMAC10.html) |
| IL (1) | IL108247A (cg-RX-API-DMAC10.html) |
| MX (1) | MX9400177A (cg-RX-API-DMAC10.html) |
| NO (1) | NO940028D0 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ250580A (cg-RX-API-DMAC10.html) |
| PL (1) | PL175365B1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW264473B (cg-RX-API-DMAC10.html) |
| UY (1) | UY23706A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA939806B (cg-RX-API-DMAC10.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522176D0 (en) * | 1995-10-30 | 1996-01-03 | Iaf Biochem Int | Morphinan derivatives having neuroprotective activity |
| EP0812827B1 (en) * | 1996-06-13 | 2009-09-02 | Sumitomo Chemical Company, Limited | Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation |
| FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
| GB9706753D0 (en) * | 1997-04-03 | 1997-05-21 | Pharmacia & Upjohn Spa | Aralkoxy-morphinan derivatives |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| WO2003097608A2 (en) * | 2002-05-17 | 2003-11-27 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| US20040204862A1 (en) | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP5784507B2 (ja) * | 2009-02-23 | 2015-09-24 | マリンクロッド エルエルシー | （＋）−モルフィナニウム第四級塩およびその生成方法 |
| CN103044327B (zh) * | 2013-01-07 | 2014-12-17 | 苏州立新制药有限公司 | 一种右美沙芬的制备方法 |
| TWI869633B (zh) * | 2014-09-14 | 2025-01-11 | 美商阿瓦尼爾製藥股份有限公司 | 用於治療失智症中躁動行為之包含右旋美索芬(dextromethorphan)化合物及奎尼丁(quinidine)的藥學組成物 |
| US20160243112A1 (en) * | 2015-02-25 | 2016-08-25 | Alkermes, Inc. | Treatments for alzheimer's related diseases and disorders |
| EP4206203A4 (en) * | 2020-08-28 | 2024-12-11 | Nippon Chemiphar Co., Ltd. | PROCESS FOR PREPARING A MORPHINAN DERIVATIVE WITH A MAIN CHAIN FORMED FROM DIARYL ETHER USING A NOVEL COPPER CATALYST |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI773636A7 (fi) * | 1976-12-06 | 1978-06-07 | Hoffmann La Roche | Nya fenylderivat |
| US4113729A (en) * | 1976-12-06 | 1978-09-12 | Hoffmann-La Roche Inc. | 3-Phenoxymorphinans and derivatives thereof |
| US4806543A (en) * | 1986-11-25 | 1989-02-21 | Board Of Trustees Of The Leland Stanford Junior University | Method and compositions for reducing neurotoxic injury |
-
1993
- 1993-11-25 TW TW082109942A patent/TW264473B/zh active
- 1993-11-30 CA CA002110337A patent/CA2110337A1/en not_active Abandoned
- 1993-12-20 DE DE69311887T patent/DE69311887T2/de not_active Expired - Fee Related
- 1993-12-20 AT AT93120498T patent/ATE154931T1/de not_active IP Right Cessation
- 1993-12-20 DK DK93120498.6T patent/DK0612730T3/da active
- 1993-12-20 EP EP93120498A patent/EP0612730B1/en not_active Expired - Lifetime
- 1993-12-20 ES ES93120498T patent/ES2105061T3/es not_active Expired - Lifetime
- 1993-12-23 NZ NZ250580A patent/NZ250580A/en unknown
- 1993-12-30 ZA ZA939806A patent/ZA939806B/xx unknown
- 1993-12-30 JP JP5354172A patent/JP2501298B2/ja not_active Expired - Lifetime
- 1993-12-31 UY UY23706A patent/UY23706A1/es unknown
- 1993-12-31 AU AU52807/93A patent/AU681601B2/en not_active Ceased
- 1993-12-31 IL IL108247A patent/IL108247A/en not_active IP Right Cessation
-
1994
- 1994-01-03 HU HU9400002A patent/HUT66061A/hu unknown
- 1994-01-03 MX MX9400177A patent/MX9400177A/es not_active IP Right Cessation
- 1994-01-04 KR KR1019940000067A patent/KR940018094A/ko not_active Ceased
- 1994-01-04 NO NO940028A patent/NO940028D0/no unknown
- 1994-01-05 BR BR9400021A patent/BR9400021A/pt not_active Application Discontinuation
- 1994-01-05 PL PL94301784A patent/PL175365B1/pl unknown
- 1994-01-05 CZ CZ9422A patent/CZ2294A3/cs unknown
- 1994-01-05 FI FI940041A patent/FI940041L/fi unknown
- 1994-01-05 CN CN94100181A patent/CN1097006A/zh active Pending
-
1995
- 1995-06-19 HU HU95P/P00253P patent/HU211290A9/hu unknown
-
1997
- 1997-09-30 GR GR970402538T patent/GR3024891T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9400002D0 (en) | 1994-05-30 |
| IL108247A (en) | 1998-02-22 |
| CZ2294A3 (en) | 1994-07-13 |
| PL301784A1 (en) | 1994-07-11 |
| ES2105061T3 (es) | 1997-10-16 |
| NZ250580A (en) | 1996-07-26 |
| DE69311887T2 (de) | 1998-01-15 |
| DK0612730T3 (da) | 1998-02-02 |
| EP0612730B1 (en) | 1997-07-02 |
| JPH06316564A (ja) | 1994-11-15 |
| PL175365B1 (pl) | 1998-12-31 |
| JP2501298B2 (ja) | 1996-05-29 |
| NO940028L (cg-RX-API-DMAC10.html) | 1994-07-07 |
| AU681601B2 (en) | 1997-09-04 |
| EP0612730A1 (en) | 1994-08-31 |
| TW264473B (cg-RX-API-DMAC10.html) | 1995-12-01 |
| HUT66061A (en) | 1994-09-28 |
| MX9400177A (es) | 1994-07-29 |
| FI940041A7 (fi) | 1994-07-07 |
| HU211290A9 (en) | 1995-11-28 |
| AU5280793A (en) | 1994-07-14 |
| FI940041A0 (fi) | 1994-01-05 |
| FI940041L (fi) | 1994-07-07 |
| ZA939806B (en) | 1994-07-06 |
| NO940028D0 (no) | 1994-01-04 |
| GR3024891T3 (en) | 1998-01-30 |
| ATE154931T1 (de) | 1997-07-15 |
| CN1097006A (zh) | 1995-01-04 |
| UY23706A1 (es) | 1994-06-05 |
| DE69311887D1 (de) | 1997-08-07 |
| KR940018094A (ko) | 1994-08-16 |
| IL108247A0 (en) | 1994-04-12 |
| CA2110337A1 (en) | 1994-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE154931T1 (de) | Morphinan-o-arylether | |
| PT95852A (pt) | Processo para a preparacao de agentes hipoglicemicos de oxazolidinediona | |
| FI934144A0 (fi) | Morfinanderivat och medicinsk anvaendning | |
| BR8800503A (pt) | Composto isomeros(e),processo para a preparacao de um composto,composicao fungicida e processo para combater fungos | |
| FI931888A0 (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
| FI893467A0 (fi) | Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi | |
| KR930002327A (ko) | 치환된 시클로프로필아미노-1, 3, 5-트리아진 | |
| HU9301866D0 (en) | Benzoxa-condensed-ring-compounds and medical preparatives containing these compounds and processes for production of these compounds and of pharmaceutical composition | |
| PT849269E (pt) | Vinil-pirrolidina cefalosporinas com substituintes basicos | |
| AU636351B2 (en) | N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments | |
| NZ248099A (en) | Use of spiro-oxathiolane quinuclidine derivatives for treating sjoegren syndrome | |
| PT597423E (pt) | Composto azetidinona e processo para a sua preparacao. | |
| PT95978A (pt) | Processo para de novos derivados do 6-aril-5,6-dihidroimidazo/2,l-b/-tiazol comefeito imuno-estimulante | |
| BR9103665A (pt) | Composicao inseticida e processo para a producao de um composto | |
| PT89098A (pt) | Processo para a preparacao de derivados de guanina | |
| FI906021A0 (fi) | Oxetanderivat, framstaellning av dessa samt anvaendning som svampmotverkande eller foerstoerande aemnen. | |
| DE69232980D1 (de) | Pyrroloazepinderivate | |
| BR9305752A (pt) | Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona | |
| FI933928A0 (fi) | Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel | |
| ATE125261T1 (de) | 2-tetrahydrofuran-enantiomerderivate, zwischenprodukte davon und ihre herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EE | Request for examination | ||
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal | ||
| FC | Decision: refusal |